Protecting against ferroptosis in hyperuricemic nephropathy: The potential of ferrostatin-1 and its inhibitory effect on URAT1-Reference-Cited by-同舟云学术

Protecting against ferroptosis in hyperuricemic nephropathy: The potential of ferrostatin-1 and its inhibitory effect on URAT1

Published:2024-05 Issue: Volume:971 Page:176528
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Li Yongmei,Zheng Fengxin,Zhong Shiqi,Zhao Kunlu,Liao Hui,Liang Jiacheng,Zheng Qiang,Wu Huicong,Zhang Shifan,Cao Ying,Wu Ting,Pang Jianxin

Funder

Medical Science and Technology Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference48 articles.

1. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: pathologic implications and putative pharmacologic targets;Balakumar;Pharmacol. Res.,2020

2. Serum ferritin levels are increased in patients with glomerular diseases and proteinuria;Branten;Nephrol. Dial. Transplant.,2004

3. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase;Chen;Phytomedicine,2021

4. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study;Chou;Nephrol. Dial. Transplant.,2017

5. Ferroptosis: an iron-dependent form of nonapoptotic cell death;Dixon;Cell,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of Reactive Oxygen Species-Guided Immune Responses in Gouty Arthritis and Potential Therapeutic Targets;Biomolecules;2024-08-09

2. The Metabolic Syndrome: An Overview and Proposed Mechanisms;Obesities;2024-07-22